Lishan Aklog's Net Worth
$17.4 Million
Who is Lishan Aklog?
Lishan Aklog has an estimated net worth of $17.4 Million. This is based on reported shares across multiple companies, which include Viveon Health Acquisition Corp., CONTRAFECT Corp, PAVmed Inc., and Lucid Diagnostics Inc..
SEC CIK
Lishan Aklog's CIK is 0001665074
Past Insider Trading and Trends
2016 was Lishan Aklog's most active year for acquiring shares with 64 total transactions. Lishan Aklog's most active month to acquire stocks was the month of July. 2018 was Lishan Aklog's most active year for disposing of shares, totalling 8 transactions. Lishan Aklog's most active month to dispose stocks was the month of March. 2022 saw Lishan Aklog paying a total of $140,700.00 for 377,000 shares, this is the most they've acquired in one year. In 2022 Lishan Aklog cashed out on 79,636 shares for a total of $93,970.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Viveon Health Acquisition Corp. (VHAQ) Snapshot price: $11.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 27K |
—
|
—
| 27K |
Dec 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONTRAFECT Corp (CFRX) Snapshot price: $0.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PAVmed Inc. (PAVM) Snapshot price: $1.9195
Chairman and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -31.12% | -79.64K |
$1.18 | -$93,970.48 | 176.28K |
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +13.56% | 150K |
—
|
—
| 1.26M |
Apr 1
| |||
Form 4
| +0.68% | 7.5K |
$4.31 | $32,323.50 | 1.11M |
Mar 18
| |||
Form 4
| +29.47% | 250K |
—
|
—
| 1.1M |
Apr 30
| |||
Form 4
| +3.67% | 30K |
$1.10 | $32,850.00 | 848.41K |
May 23
| |||
Form 4
| +32.34% | 200K |
—
|
—
| 818.41K |
Mar 15
| |||
Form 4
| +5.10% | 30K |
$1.18 | $35,400.00 | 618.41K |
Aug 28
| |||
Form 4
| +77.29% | 2K |
—
|
—
| 4.58K |
Apr 20 - Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
| -5.49% | -34.15K |
—
|
—
| 588.41K |
Feb 2 - Feb 14
| |||
Form 4
| -1.14% | -66.12K |
$4.30 | $5,160.00 | 5.72M |
Nov 21 - Nov 22
| |||
Form 4
| +2.26% | 1.55K |
—
|
—
| 70.29K |
Nov 17 - Nov 20
| |||
Form 4
| +3.93% | 2.6K |
—
|
—
| 68.74K |
Sep 15
| |||
Form 4
| +1.07% | 700 |
$6.66 |
—
| 66.14K |
Sep 11 - Sep 13
| |||
Form 4
| +1.95% | 1.25K |
—
|
—
| 65.44K |
Sep 7 - Sep 8
| |||
Form 4
| +2.72% | 1.7K |
—
|
—
| 64.19K |
Sep 5 - Sep 6
| |||
Form 4
| +6.13% | 3.61K |
—
|
—
| 62.49K |
Aug 29 - Sep 1
| |||
Form 4
| +1.55% | 900 |
—
|
—
| 58.88K |
Aug 25
| |||
Form 4
| +18.62% | 9.1K |
—
|
—
| 57.98K |
Aug 23 - Aug 24
| |||
Form 4
| +22.57% | 9K |
—
|
—
| 48.88K |
Aug 21 - Aug 22
| |||
Form 4
| +34.33% | 10.2K |
—
|
—
| 39.91K |
Aug 17 - Aug 18
| |||
Form 4
| +6.64% | 1.89K |
$3.28 | $6,161.10 | 30.26K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| +10.85% | 2.78K |
$9.21 | $25,565.65 | 28.38K |
Nov 28 - Nov 29
| |||
Form 4
| +9.40% | 2.2K |
$8.98 | $19,766.78 | 25.6K |
Nov 23
| |||
Form 4
| +10.90% | 2.3K |
$10.02 | $23,035.72 | 23.4K |
Nov 18 - Nov 21
| |||
Form 4
| +6.57% | 1.3K |
$14.05 | $18,264.90 | 21.1K |
Aug 23 - Sep 16
| |||
Form 4
| +8.20% | 1.5K |
$13.40 | $20,103.30 | 19.8K |
Sep 1 - Sep 14
| |||
Form 4
| +2.23% | 400 |
$14.30 | $5,720.00 | 18.3K |
Aug 25 - Aug 26
| |||
Form 4
| +9.15% | 1.5K |
$14.22 | $21,322.50 | 17.9K |
Aug 23 - Aug 24
| |||
Form 4
| +17.14% | 2.4K |
—
|
—
| 16.4K |
May 27 - May 31
| |||
Form 4
| +40.00% | 4K |
—
|
—
| 14K |
May 25 - May 26
| |||
Form 4
| +96.08% | 4.9K |
—
|
—
| 10K |
May 23 - May 24
| |||
Form 4
| +155.00% | 3.1K |
—
|
—
| 5.1K |
May 19 - May 20
| |||
Form 4
| +2,300.00% | 2.3K |
—
|
—
| 2.4K |
May 17 - May 18
| |||
Form 4
| +9.73% | 244.02K |
—
|
—
| 2.75M |
Apr 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lucid Diagnostics Inc. (LUCD) Snapshot price: $1.3003
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +10.63% | 60K |
—
|
—
| 624.4K |
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||